# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 14일


## 주요 헤드라인

1. **Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-closes-metsera-deal-officially-ending-bidding-war-drama>

2. **Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-closes-metsera-deal-officially-ending-bidding-war-drama>

3. **Korro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/korro-suffers-cacophony-of-bad-news-as-lead-candidate-fails-novo-pauses-rna-deal>

4. **Korro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/korro-suffers-cacophony-of-bad-news-as-lead-candidate-fails-novo-pauses-rna-deal>

5. **Zealand Freezes Mid-Stage Obesity Asset to Focus on More Differentiated Drugs (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/zealand-freezes-mid-stage-obesity-asset-to-focus-on-more-differentiated-drugs>

6. **AbbVie Ends 11-Year Relationship With Calico, Lays Off 100+ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/abbvie-ends-11-year-relationship-with-calico-lays-off-100>

7. **Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/alkermes-pushes-narcolepsy-program-to-phase-iii-with-highly-competitive-mid-stage-data>


---
*2025년 11월 14일 바이오스페이스 뉴스 피드에서 생성된 리포트*